StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research note released on Monday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 0.6 % Shares of BTX opened at $3.27 on Monday. Brooklyn ImmunoTherapeutics has a 12-month low of $0.17 and a 12-month high […]